Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

United States Percutaneous Transhepatic Cholangiography (PTC) Pancreatic and Biliary Stenting Procedures Outlook to 2023

Reportlinker
Posted on: 29 Jul 17

NEW YORK, July 27, 2017 /PRNewswire/ --

Summary

GlobalData's new report, "United States Percutaneous Transhepatic Cholangiography (PTC) Pancreatic and Biliary Stenting Procedures Outlook to 2023", provides key procedures data on the United States Percutaneous Transhepatic Cholangiography (PTC) Pancreatic and Biliary Stenting Procedures. The report provides procedure volumes within market segments - PTC Plastic Pancreatic and Biliary Stenting Procedures and PTC Metal Pancreatic and Biliary Stenting Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- United States Percutaneous Transhepatic Cholangiography (PTC) Pancreatic and Biliary Stenting Procedures volumes by segments - PTC Plastic Pancreatic and Biliary Stenting Procedures and PTC Metal Pancreatic and Biliary Stenting Procedures.
- Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.
Read the full report: http://www.reportlinker.com/p04928861/United-States-Percutaneous-Transhepatic-Cholangiography-PTC-Pancreatic-and-Biliary-Stenting-Procedures-Outlook-to.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

For more information:
www.reportlinker.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 29/07/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.